Developer of genome-scale sequencing technology designed to offer analytical services to enterprises.
Developer of genome-scale sequencing technology designed to offer analytical services to enterprises.
Biotechnology📍 Fremont, CAFounded 2016
Current Valuation
$3.6B
as of 2022-Q2
UNICORN
QL Price
$2.0B
-45% vs last round
QuantLogix's current estimate for Ultima Genomics, published 2026-11-12 — below the last disclosed round of $3.6B (2022-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$3.6B
2022-Q2
weight 0.05
Secondary market print
$1.8B
2026-06-27
weight 0.44
How this price has held up
No round has priced for Ultima Genomics since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-11-12 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Ultima Genomics, 2026-11-12 (8d6351b1b3d8b229).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Ultima Genomics going public?
No. Ultima Genomics is private and has not filed to go public. There is no S-1 on file.
What is Ultima Genomics' valuation in 2026?
Ultima Genomics is valued at $3.6B as of 2022-Q2, set by its Series E ($229.25M, May 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Ultima Genomics filed an S-1?
No public S-1 is on file for Ultima Genomics.
How much has Ultima Genomics raised?
Ultima Genomics has raised $600M in total, most recently a Series E of $229.25M in May 2022.
Is Ultima Genomics publicly traded — can you buy Ultima Genomics stock?
No. Ultima Genomics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Ultima Genomics on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
Fremont, CA
Employees
304
Total Raised
$600M
Last Round
Series E — $229.25M (May 2022)
IPO Status
private
Fundraising Status
Series E · $229.25M · 4y 6mo ago
privateTotal raised $600M
Secondary Market
Implied price / share
$24.96
Last round price / share
$50.14
vs last round
-50.2%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series E
$229.25M
May 2022
—
$3.6B
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Ultima Genomics — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-11-12. Re-checked weekly.
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-10
Open roles
16
via greenhouse
Product-build share
63%
engineering, research, product, design
Trajectory
steady
product-led hiring — 63% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Electrical Engineer IIField Service Engineer I, Development ProgramField Service Engineer II, ArizonaField Service Engineer II, UAEFirmware Engineer ISenior Electrical Engineer
Counted from Ultima Genomics's live job board as of 2026-11-12; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalHealth CareBiotechnologyLife Science
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.